Page last updated: 2024-11-04

tegafur and Gestational Trophoblastic Disease

tegafur has been researched along with Gestational Trophoblastic Disease in 1 studies

Gestational Trophoblastic Disease: A group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peng, M1
Ding, Y1
Yu, L1
Deng, Y1
Lai, W1
Hu, Y1
Zhang, H1
Wu, X1
Fan, H1
Ding, H1
Wu, Y1
Tao, G1

Other Studies

1 other study available for tegafur and Gestational Trophoblastic Disease

ArticleYear
Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Fluorouracil; Gestation

2015